在急性呼吸困难综合征中使用类固醇:灵丹妙药还是仍然是一个难题?
Sharmili Sinha1, Rohit Patnaik2, Srikant Behera3
1Department of Critical Care Medicine, Apollo Hospitals, Bhubaneswar 751005, Odisha, India. sromsinha1011@gmail.com.
World journal of critical care medicine
|June 10, 2024
概括
皮质类固醇在治疗急性呼吸困扰综合征 (ARDS) 中表现有前途,但感染和高血糖症等潜在副作用需要仔细考虑. 需要进一步的研究来确定最受益于这种ARDS治疗的特定患者群体.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 呈现出多种原因和复杂的病理生理学.
- 目前的治疗主要集中在呼吸支上,对于不同严重程度的药物疗法只有有限的共识.
- 皮质类固醇正在探索它们有助于ARDS解决的潜力.
研究的目的:
- 审查当前关于皮质类固醇在治疗ARDS中的作用和影响的证据.
- 突出在ARDS患者中使用皮质类固醇的潜在好处和风险.
主要方法:
- 对现有临床试验和文献进行系统审查.
- 对有关ARDS的皮质类固醇疗效和不良事件的数据的分析.
- 评估不同ARDS严重程度和患者子组的证据.
主要成果:
- 皮质类固醇显示出改善ARDS解决方案的潜力.
- 副作用包括高血糖,增加在医院获得感染的风险,以及在ICU获得的虚弱.
- 几十年的研究显示出不同的结果,需要进一步调查.
结论:
- 皮质类固醇在ARDS治疗中可能有好处,但对副作用的仔细监测至关重要.
- 确定从皮质类固醇中获益最多的特定患者亚组对于更广泛的实施至关重要.
- 需要进行额外的严格试验,以完善在ARDS治疗中使用皮质类固醇.
相关概念视频
Acute Respiratory Failure-V
132
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
132
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
Drugs Used in Lower Respiratory Disorders: Overview
420
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
420
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Antiasthma Drugs: β2-Adrenoceptor Agonists
249
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
249
Acute Respiratory Failure-IV
148
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
148


